An erectile dysfunction pill is not a great diagnostic. 

In fact, only 35% of men respond to the pill at first prescription, and only 30% of men use the pill after 6-12 months.  Current diagnosis and monitoring is frustrating and complex for patients.

AndroScan is the world's first wearable device to help diagnose and monitor erectile dysfunction.  The device can be used by patients and physicians to diagnose the type of erectile dysfunction as well as what treatment actually works.

AndroScan is distributed by GOTOP Medical and is currently pending FDA submission.

For more information, please contact:

Andro360, Inc.
9825 Carroll Centre Rd #300c
San Diego, CA 92126

Andro360 Logo